EFPIA Newsletter 28 May 2025

EFPIA highlights three priorities to boost Europe's competitiveness at the Euractiv Conference How can we boost Europe’s competitiveness? Ensure all legislations are coherent and don't have unintended consequences on pharmaceuticals Strengthen Europe’s intellectual property provisions Reward innovation: investing in health is not a cost, but an investment Hear more from Roberta Savli, EFPIA Executive Director of Public Affairs, at the 2025 Euractiv Health Policy Conference.

Vaccination against respiratory infections can reduce the risk of complications associated with CVD

Respiratory infections can increase the risk of CVDs among all people. Studies show that for CVD patients diagnosed with flu, the risk of experiencing a heart attack increases 6-fold. Additionally, patients have a 3 times increased risk of experiencing a stroke after a systemic respiratory infection.   Learn how vaccination can be a strategic tool for protecting cardiovascular health across Europe.

Events     23 JUN 2025   IHI Call Days - call 11 Virtual event The IHI Call Days for IHI call 11 will take place from 23 to 30 June 2025 online and will include sessions on the individual... Learn more →       24 JUN 2025   EU-X-CT Public Stakeholder Conference: Final recommendations launch Brussels, hybrid event Borders should no longer be barriers in clinical trials. Learn more →

	25 JUN 2025			FACILITATE 2025 Webinar - Return of individual participant data in clinical trials... Virtual event Organised by Active Citizenship Network, this webinar will bring together key voices from across sectors to explore... Learn more →

	06 OCT 2025			Biotech Business Mission to Japan 2025 - Call for applications Osaka & Yokohama, Japan Join the biotech business mission in Japan from 6-10 October 2025, organised by the EU-Japan Centre for Industrial Cooperation.... Learn more →

What we are reading Getting medicine to children with cancer faster with ITCC-P4 27 May 2025  (IHI) Read more → IRDiRC - Funding Models to support the spectrum of rare disease research and development 20 May 2025  (IRDiRC) Read more → The European Health Data Space 17 May 2025  (The Lancet) Read more → Prioritising Alzheimer’s disease policy in Europe: Insights from oncology 15 May 2025  (CRA) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe